CSI Market
Sign In | Register

Silexion Therapeutics (SLXN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SLXN Annual Balance Sheets →
A period-by-period view of the balance sheet from Silexion Therapeutics to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent2.23
Restricted Cash and Cash Equivalents, Current0.03
Cash & Short-term Investments2.00
Other Current Assets0.11
Prepaid Expense, Current AS1.37
Total Current Assets3.74
Equipment/Property/Plant Net0.02
Deposits Assets, Noncurrent AS0.08
Other Assets, Noncurrent0.41
Restricted Cash Noncurrent0.06
Operating Lease Right Of Use Asset0.38
Total Assets4.25
Liabilities
Accounts Payable0.98
Employee-related Liabilities, Current AC0.93
Other Liabilities, Current2.06
Total Current Liabilities3.98
Total Long-term Debt0.00
Other liabilities, Noncurrent0.14
Operating Lease Liability Current0.19
Private Warrant To Purchase Ordinary Shares-
Operating Lease Liability Noncurrent0.25
Promissory Notes To Related Parties-
Total Liabilities4.20
Stockholders' Equity
Common Stock Value0.16
Additional Paid In Capital Common Stock61.33
Retained Earnings / Accumulated Deficit-61.45
Other Equity0.00
Common Stockholder's Equity0.04
Total Stockholder's Equity0.04
Liabilities & Stockholder's Equity4.25
4 historic quarters locked

Sign in to unlock the full Silexion Therapeutics balance sheet history.

Sign In Create Free Account

About Silexion Therapeutics Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: zk2635847.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001178913-26-004138

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.